Cargando…
A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease
BACKGROUND: There is considerable interest in the possible importance of the gut microflora in the pathophysiology of the inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD). Probiotics offer a potential adjuvant treatment in these patients by modifying the intestinal...
Autores principales: | Bjarnason, Ingvar, Sission, Guy, Hayee, Bu’Hussaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554453/ https://www.ncbi.nlm.nih.gov/pubmed/31054010 http://dx.doi.org/10.1007/s10787-019-00595-4 |
Ejemplares similares
-
Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison
por: Kawakami, Aki, et al.
Publicado: (2022) -
Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study
por: Kawakami, Aki, et al.
Publicado: (2022) -
The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature
por: Vakadaris, Georgios, et al.
Publicado: (2023) -
Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial
por: Sung, Valerie, et al.
Publicado: (2014) -
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease
por: Schölmerich, Jürgen, et al.
Publicado: (2017)